Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR
e-SSRS-IVR
1 other identifier
observational
20
1 country
1
Brief Summary
The proposed study is designed to evaluate the clinical contents of the e-SSRS-IVR with respect to 1.the intent of the instrument (assess face and content validity), 2. system validation with respect to programming integrity, 3. implementation feasibility in clinical ill and healthy patient populations, and 4. criterion/predictive validity to discriminate patient population with known clinical status differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 15, 2009
CompletedFirst Posted
Study publicly available on registry
June 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJune 16, 2009
June 1, 2009
1 month
June 15, 2009
June 15, 2009
Conditions
Keywords
Study Arms (2)
Hospital Patients/Hospital Employees
Hospital employees
A group of 10 hospital employees used as baseline
Eligibility Criteria
Study subjects will be recruited from a single clinical site (Rogers Memorial Hospital, Milwaukee WI). Half of the subjects will be recruited through public advertisement for Rogers Hospital employees and the other half will be recruited from recent inpatient psychiatric admissions.
You may qualify if:
- English speaking adults, able/willing to read and provide written consent
You may not qualify if:
- Dementia, delirium, psychosis or deafness.
- Control subjects will be excluded for any MINI lifetime MDD or dysthymia diagnosis of a DSM-IV disorder except for specific phobia or dependence on nicotine and caffeine.
- Inpatients not admitted with suicidal ideations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rogers Center for Research & Training, Inc.lead
- GlaxoSmithKlinecollaborator
Study Sites (1)
Rogers Center for Research and Training, Inc
Milwaukee, Wisconsin, 53227, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
John H Greist, MD
Rogers center for Research and Training, Inc
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 15, 2009
First Posted
June 16, 2009
Study Start
June 1, 2009
Primary Completion
July 1, 2009
Study Completion
August 1, 2009
Last Updated
June 16, 2009
Record last verified: 2009-06